BioNTech SE Other Current Liabilities

BioNTech SE (BNTX) currently reports a other current liabilities of $480M as of March 2026. That compares with $740M in the prior-year period — down 34.5% year over year. Use the charts on this page to explore BioNTech SE's other current liabilities history and peer comparisons.

BioNTech SE's other current liabilities decreased from $740M to $480M — a 34.5% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioNTech SE reported $480M in other current liabilities as of March 2026. That compares with $740M in the prior-year period — down 34.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $480M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioNTech SE, and consider following BNTX for alerts when major investors trade the stock.

BioNTech SE is classified in the Healthcare sector. On other current liabilities, it currently shows $480M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BNTX with unrelated industries.